Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575 A letter to the editor is presented in response to the article on the developed drugs in Japan for the prevention or treatment of hyperpigmentary ...
Drugs and the Politics of Consumption in Japanchristen@rose-hulman.eduPaul Christensen
The overdose of drugs in Japan.: The Japanese consume enormous amounts of drugs on prescription, some of which are not legally available elsewhere in the world.
This webinar aims to shed light on the regulatory requirements of quasi-drugs in Japan. In the webinar, Ms. Rose Hong, the regulatory analyst from ChemLinked, will introduce the definition, classification, regulated ingredient requirement, import procedures, etc. of quasi-drugs, offering a prelimin...
In Japan, non-prescription drugs are classified under three categories: Class 1 Drugs, Class 2 Drugs, and Class 3 Drugs. Collectively they are known asOTC (over-the-counter) drugs. Patients are free to seek the advice of a pharmacist before purchasing OTC drugs. ...
would like to emphasize that other regulatory agencies may have approved the same compounds earlier than the FDA (among this year’s approvals, e.g., toripalimab and fruquintinib in China and daprodustat in Japan), may do so at later points in time, may choose not to approve some of...
All three of these compounds are undergoing phase 3 trials or have been approved abroad, and because they are in the final stage of development in Japan, they are expected to be introduced in clinical settings in the near future. After they have been introduced, it will be necessary to ...
In accordance with the clinical hold, the FDA provided that no new clinical trials that included dosing with sovaprevir could be initiated, however, the FDA allowed continued enrollment and treatment of patients in the Phase 2 -007 clinical trial evaluating 12-weeks of sovaprevir in combination...
A hospital in Japan provided postpartum mothers with a combination tablet containing tramadol 37.5 mg and acetaminophen 325 mg every 6 hours for 3 days if they requested a pain medication. A retrospective analysis found that of 148 mothers who received the drug, all infants were breastfed and ...
No differences were found in the changes in serum prolactin, infant weight gain or amount of supplementation between the treatment and placebo groups after 4 weeks of therapy. No side effects or changes in liver function tests occurred during the study.[13] A study in Japan compared the use ...